Screening of immigrants in the UK for imported latent tuberculosis: A multicentre cohort study and cost-effectiveness analysis

The Lancet Infectious Diseases

Volumn 11, Issue 6, 2011, Pages 435-444

  Pareek, Manish ^a   Watson, John P ^c   Ormerod, L Peter ^d   Kon, Onn Min ^e   Woltmann, Gerrit ^f   White, Peter J ^g   Abubakar, Ibrahim ^g   Lalvani, Ajit ^b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^d ROYAL BLACKBURN HOSPITAL   (United Kingdom)

^e IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^f UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^g PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BCG VACCINATION; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; FEMALE; HUMAN; IMMIGRANT; INCIDENCE; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UNITED KINGDOM;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COST-BENEFIT ANALYSIS; DECISION TREES; EMIGRANTS AND IMMIGRANTS; FEMALE; GREAT BRITAIN; HUMANS; INCIDENCE; INTERFERON-GAMMA; LATENT TUBERCULOSIS; MALE; MASS SCREENING; PREVALENCE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; YOUNG ADULT;

EID: 79956266431     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(11)70069-X     Document Type: Article

References (59)

1. Migrant health: background note to the " ECDC report on migration and infectious diseases in the EU" European Centre for Disease Prevention and Control, (accessed Nov 1, 2010). http://www.ecdc.europa.eu/en/publications/Publications/0907_TER_Migrant_health_Background_note.pdf.
2. Tuberculosis in the UK: report on tuberculosis surveillance and control in the UK 2010 Health Protection Agency, (accessed Nov 21, 2010). http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1287143594275.
3. Total TB cases and TB notification rates, 1995-2006, WHO European Region 2006 EuroTB, (accessed Nov 1, 2010). http://www.eurotb.org/slides/2008/TBCases_Rates1995-2006.pdf.
4. Total internal migration (TIM) tables. 1991-present Office for National Statistics, (accessed Nov 1, 2010). http://www.statistics.gov.uk/StatBase/Product.asp?vlnk=507.
5. Gilbert RL, Antoine D, French CE, Abubakar I, Watson JM, Jones JA The impact of immigration on tuberculosis rates in the United Kingdom compared with other European countries. Int J Tuberc Lung Dis 2009, 13:645-651.
6. Maguire H, Dale JW, McHugh TD, et al. Molecular epidemiology of tuberculosis in London 1995-7 showing low rate of active transmission. Thorax 2002, 57:617-622.
7. French CE, Antoine D, Gelb D, Jones JA, Gilbert RL, Watson JM Tuberculosis in non-UK-born persons, England and Wales, 2001-2003. Int J Tuberc Lung Dis 2007, 11:577-584.
8. Tuberculosis in the UK: annual report on tuberculosis surveillance and control in the UK 2009 Health Protection Agency, (accessed Nov 21, 2010). http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1259152022594.
9. Moore-Gillon J, Davies PD, Ormerod LP Rethinking TB screening: politics, practicalities and the press. Thorax 2010, 65:663-665.
10. Alvarez GG, Gushulak B, Abu Rumman K, et al. A comparative examination of tuberculosis immigration medical screening programs from selected countries with high immigration and low tuberculosis incidence rates. BMC Infect Dis 2010, 11:3.
11. Medical examination under the Immigration Act 1971: instructions to medical inspectors Department of Health, (accessed Nov 1, 2010). http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4111790.pdf.
12. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control National Institute for Health and Clinical Excellence, (accessed Nov 1, 2010). http://www.nice.org.uk/nicemedia/pdf/CG033niceguideline.pdf.
13. Pareek M, Abubakar I, White PJ, Garnett GP, Lalvani A TB screening of migrants to low TB burden nations: insights from evaluation of UK practice. Eur Respir J 2010, published online Nov 11. 10.1183/09031936.00105810.
14. Mazurek GH, Jereb J, Vernon A, et al. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection-United States, 2010. MMWR Recomm Rep 2010, 59:1-25. for the Centers for Disease Control and Prevention (CDC).
15. Hardy AB, Varma R, Collyns T, Moffitt SJ, Mullarkey C, Watson JP Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries. Thorax 2010, 65:178-180.
16. Lalvani A Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy. Chest 2007, 131:1898-1906.
17. Lalvani A, Pathan AA, Durkan H, et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 2001, 357:2017-2021.
18. Ewer K, Deeks J, Alvarez L, et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003, 361:1168-1173.
19. Haldar P, Thuraisingham H, Hoskyns W, Woltmann G Contact screening with single-step TIGRA testing and risk of active TB infection: the Leicester cohort analysis. Thorax 2009, 64(suppl):A10.
20. Yoshiyama T, Harada N, Higuchi K, Sekiya Y, Uchimura K Use of the QuantiFERON-TB Gold test for screening tuberculosis contacts and predicting active disease. Int J Tuberc Lung Dis 2010, 14:819-827.
21. Kik SV, Franken WP, Mensen M, et al. Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts. Eur Respir J 2010, 35:1346-1353.
22. Diel R, Loddenkemper R, Niemann S, Meywald-Walter K, Nienhaus A Negative and positive predictive value of a whole-blood IGRA for developing active TB-an update. Am J Respir Crit Care Med 2010, published online Aug 27. DOI:201006-0974OC.
23. Bakir M, Millington KA, Soysal A, et al. Prognostic value of a T-cell based, interferon-gamma biomarker in children with tuberculosis contact. Ann Intern Med 2008, 149:777-787.
24. Leung CC, Yam WC, Yew WW, et al. T-Spot.TB outperforms tuberculin skin test in predicting tuberculosis disease. Am J Respir Crit Care Med 2010, 182:834-840.
25. Doherty TM, Demissie A, Olobo J, et al. Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol 2002, 40:704-706.
26. Aichelburg MC, Rieger A, Breitenecker F, et al. Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals. Clin Infect Dis 2009, 48:954-962.
27. Lienhardt C, Fielding K, Hane AA, et al. Evaluation of the prognostic value of IFN-γ release assay and tuberculin skin test in household contacts of infectious tuberculosis cases in Senegal. PLoS One 2010, 5:e10508.
28. Mahomed H, Hawkridge T, Verver S, et al. The tuberculin skin test versus QuantiFERON TB Gold in predicting tuberculosis disease in an adolescent cohort study in South Africa. PLoS One 2011, 6:e17984.
29. Bakir M, Dosanjh DP, Deeks JJ, et al. Use of T cell-based diagnosis of tuberculosis infection to optimize interpretation of tuberculin skin testing for child tuberculosis contacts. Clin Infect Dis 2009, 48:302-312.
30. Final mid-2009 population estimates: quinary age groups for primary care organisations in England; estimated resident population (experimental) Office for National Statistics, (accessed Nov 23, 2010). http://www.statistics.gov.uk/statbase/product.asp?vlnk=15106.
31. Country of birth by primary care organisation (table UV08) Office for National Statistics, (accessed Nov 23, 2010). http://www.neighbourhood.statistics.gov.uk/dissemination/.
32. Global tuberculosis control: epidemiology, strategy, financing WHO, (accessed Oct 31, 2010). http://whqlibdoc.who.int%20publications/2009/9789241563802_eng.pdf.
33. Diel R, Loddenkemper R, Nienhaus A Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a meta-analysis. Chest 2010, 137:952-968.
34. Lalvani A, Pareek M A 100 year update on diagnosis of tuberculosis infection. Br Med Bull 2009, 93:69-84.
35. Immunisation against infectious disease. In: Salisbury D, Ramsay M, Noakes K, eds. 2006 Department of Health, (accessed Nov 23, 2010). http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_125349.pdf.
36. Global tuberculosis control: epidemiology, strategy, financing WHO, (accessed Oct 31, 2010). http://whqlibdoc.who.int/publications/2009/9789241563802_eng.pdf.
37. Orlando G, Merli S, Cordier L, et al. Interferon-γ releasing assay versus tuberculin skin testing for latent tuberculosis infection in targeted screening programs for high risk immigrants. Infection 2010, 38:195-204.
38. Gibney KB, Mihrshahi S, Torresi J, Marshall C, Leder K, Biggs BA The profile of health problems in African immigrants attending an infectious disease unit in Melbourne, Australia. Am J Trop Med Hyg 2009, 80:805-811.
39. Haley CA, Cain KP, Yu C, Garman KF, Wells CD, Laserson KF Risk-based screening for latent tuberculosis infection. South Med J 2008, 101:142-149.
40. Carvalho AC, Pezzoli MC, El-Hamad I, et al. QuantiFERON-TB Gold test in the identification of latent tuberculosis infection in immigrants. J Infect 2007, 55:164-168.
41. Kik SV, Franken WP, Arend SM, et al. Interferon-gamma release assays in immigrant contacts and effect of remote exposure to Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2009, 13:820-828.
42. Bodenmann P, Vaucher P, Wolff H, et al. Screening for latent tuberculosis infection among undocumented immigrants in Swiss healthcare centres; a descriptive exploratory study. BMC Infect Dis 2009, 9:34.
43. Soysal A, Millington KA, Bakir M, et al. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet 2005, 366:1443-1451.
44. Winje B, Oftung F, Korsvold G, et al. Screening for tuberculosis infection among newly arrived asylum seekers: Comparison of QuantiFERON TB Gold with tuberculin skin test. BMC Infect Dis 2008, 8:65.
45. Lien LT, Hang NT, Kobayashi N, et al. Prevalence and risk factors for tuberculosis infection among hospital workers in Hanoi, Viet Nam. PLoS One 2009, 4:e6798.
46. Mutsvangwa J, Millington KA, Chaka K, et al. Identifying recent Mycobacterium tuberculosis transmission in the setting of high HIV and TB burden. Thorax 2010, 65:315-320.
47. Bamford ARJ, Crook AM, Clark JE, et al. Comparison of interferon-γ release assays and tuberculin skin test in predicting active tuberculosis (TB) in children in the UK: a paediatric TB network study. Arch Dis Child; 95: 180-86.
48. Schwartzman K, Menzies D Tuberculosis screening of immigrants to low-prevalence countries. A cost-effectiveness analysis. Am J Respir Crit Care Med 2000, 161:780-789.
49. Dasgupta K, Schwartzman K, Marchand R, et al. Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreign-born populations. Am J Respir Crit Care Med 2000, 162:2079-2086.
50. Oxlade O, Schwartzman K, Menzies D Interferon-gamma release assays and TB screening in high-income countries: a cost-effectiveness analysis. Int J Tuberc Lung Dis 2007, 11:16-26.
51. Marks GB, Bai J, Simpson SE, Sullivan EA, Stewart GJ Incidence of tuberculosis among a cohort of tuberculin-positive refugees in Australia: reappraising the estimates of risk. Am J Respir Crit Care Med 2000, 162:1851-1854.
52. Choudry IW, Ormerod LP The outcome of a cohort of tuberculin positive, predominantly south Asian, new entrants aged 16-34 to the UK: Blackburn 1989-2001. Thorax 2007, 62(suppl 3):S1.
53. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control National Institute for Health and Clinical Excellence, (accessed April 2, 2011). http://www.nice.org.uk/nicemedia/live/13422/53642/53642.pdf.
54. Diel R, Nienhaus A, Loddenkemper R Cost-effectiveness of interferon-gamma release assay screening for latent tuberculosis infection treatment in Germany. Chest 2007, 131:1424-1434.
55. Pooran A, Booth H, Miller RF, et al. Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis. BMC Pulm Med 2010, 10:7.
56. Dosanjh DP, Hinks TS, Innes JA, et al. Improved diagnostic evaluation of suspected tuberculosis. Ann Intern Med 2008, 148:325-336.
57. Casey R, Blumenkrantz D, Millington K, et al. Enumeration of functional T-cell subsets by fluorescence-immunospot defines signatures of pathogen burden in tuberculosis. PLoS One 2010, 5:e15619.
58. Millington KA, Fortune SM, Low J Rv3615c is a highly immunodominant RD1 (Region of Difference 1)-dependent secreted antigen specific for Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 2011, 108:5730-5735.
59. Lalvani A, Millington KA T-cell interferon-γ release assays: can we do better?. Eur Respir J 2008, 32:1428-1430.